Takeda Pharmaceutical Company Limited Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Takeda Pharmaceutical Company Limited (TKPHF) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of 3.71 thousand JPY/shares for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2025-06-25
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-03-31 | 3.71K JPY/shares 20-F · filed 2025-06-25 |
| 2024-03-31 | 3.46K JPY/shares 20-F · filed 2025-06-25 |
| 2023-03-31 | 2.80K JPY/shares 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.00 JPY/shares 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.00 JPY/shares 20-F · filed 2023-06-28 |
| 2020-03-31 | 2.27K JPY/shares 20-F · filed 2022-06-29 |
| 2019-03-31 | 3.72K JPY/shares 20-F · filed 2021-06-29 |
| 2018-03-31 | 3.88K JPY/shares 20-F · filed 2020-06-24 |